CN Patent

CN107459519A — 稠合嘧啶哌啶环衍生物及其制备方法和应用

Assigned to Shanghai Allist Pharmaceuticals Inc · Expires 2017-12-12 · 8y expired

What this patent protects

本发明涉及下式(I)稠合嘧啶哌啶环衍生物及其药学上可接受的盐以及其制备方法，式中R 1 、R 2 、R 3 、R 4 、R 5 、X、Y和Z如说明书中所定义。还提供了所述稠合嘧啶哌啶环衍生物用于制备预防或治疗FGFR激酶介导的疾病例如癌症的药物的用途。

USPTO Abstract

本发明涉及下式(I)稠合嘧啶哌啶环衍生物及其药学上可接受的盐以及其制备方法，式中R 1 、R 2 、R 3 、R 4 、R 5 、X、Y和Z如说明书中所定义。还提供了所述稠合嘧啶哌啶环衍生物用于制备预防或治疗FGFR激酶介导的疾病例如癌症的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN107459519A
Jurisdiction
CN
Classification
—
Expires
2017-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Allist Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.